Dose Optimization Study of Idelalisib in Follicular Lymphoma

08/09/2016
23/05/2024
EU PAS number:
EUPAS15094
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

amd-2-prot GS-US-313-1580-synopsis only

English (194.63 KB - PDF) View document
Updated protocol

GS-US-313-1580-appendix-16.1.1-protocol Amendment 6_f-redact

First published: 22/02/2024
English (3.37 MB - PDF) View document
Study results
Study results

GS-US-313-1580 - CSR Synopsis_f-redact

English (630.65 KB - PDF) View document
Study report
Other information